If you’re one of the millions of Americans walking around with a new knee or hip, your odds for an infection in that joint rise if you ever have to undergo cancer chemotherapy, researchers report. “Given the number of people of receiving total joint replacements each year, as well as the cost both physically, emotionally and financially for those who develop an infection and may need subsequent treatment, we need to understand what factors may increase the risk for postoperative infections,” said study author Dr. Janet Conway. She’s an orthopedic surgeon at the Rubin Institute for Advanced Orthopedics, and is also head of Bone and Joint Infection at Sinai Hospital in Baltimore. Her team tracked outcomes for over 17,000  patients who had undergone total knee replacement, total hip replacement or total shoulder replacement. They looked at people who’d also undergone chemotherapy within a year of their joint replacement surgery. Undergoing chemo appeared tied to a higher odds for an infection in the joint that had been replaced, the team found, compared to folks with new joints who had not undergone chemo. “We became curious about the potential effects of postoperative chemotherapy and the risk of joint infection as we saw cases in our own joint replacement patients,” Conway explained in a Sinai Hospital news release.  “To our knowledge, this is the first study to comprehensively…  read on >  read on >

Memorial Day means firing up that backyard grill for the season, hopefully under warm, sunny skies. You can be sure to enjoy the day without hazards by taking a few simple precautions, said Dr. Mike Ren, an associate professor of family and community medicine at Baylor College of Medicine in Houston. Watch out for rising heat and humidity If Memorial day is a scorcher, hydration is key, Ren said. “A good rule of thumb is to drink water regularly throughout the day, aiming for 12 or more cups; when in the heat, drink one cup (eight ounces) of water roughly every 20 minutes,” he advised. And stay away from substances that can rob your body of water. “Alcohol is a diuretic, meaning it increases urine production and can lead to fluid loss,” Ren noted in a Baylor news release. “On the other hand, sugary drinks can cause spikes and crashes in blood sugar levels,” he added. “Prioritizing water consumption is crucial for maintaining proper hydration levels. If you want to add a little flavor, low or zero-sugar electrolyte powders and supplements can be a good alternative.” Shield your skin from the sun Folks may have forgotten the sun’s dangers as winter and spring ebb away. Dr. John Wolf, professor of dermatology at Baylor, recommends slapping on a sunscreen with an SPF of 30, and using…  read on >  read on >

One of the toughest decisions seniors face is when to give up their keys and stop driving. Even slight changes to the ability to remember, think and reason can lead a senior to decide to stop driving, a new study finds. Impaired cognitive function foreshadows the decision of many seniors to give up driving, even more so than age or physical changes related to Alzheimer’s disease, researchers found. And routine brain testing — in particular, screening meant to detect the earliest and most subtle decline — could help older adults make safe driving decisions while still preserving their independence, the study concluded. “Many older drivers are aware of changes occurring as they age, including subjective cognitive decline,” said researcher Ganesh Babulal, an associate professor of neurology at Washington University School of Medicine in St. Louis. “Doctors should discuss such changes with their older patients,” Babulal added in a university news release. “If risk is identified early, there is more time to support the remaining capacity and skills, extending the time they can drive safely, and to plan for a transition to alternative transportation options to maintain their independence when the time comes to stop driving.” For the study, researchers tracked 283 people with an average age of 72 who drove at least once a week and had no cognitive impairments at the start. The participants…  read on >  read on >

For decades, the responsibility for birth control has fallen largely on women, but new research suggests a birth control pill for men might one day become a reality. How does it work? It targets a protein required for fertility, scientists report. The protein, called serine/threonine kinase 33 (STK33), is enriched in the testicles and is specifically required to create functional sperm, they explained. A drug that inhibits STK33, called compound CDD-2807, blocked the ability of male lab mice to fertilize female mice, researchers reported May 23 in the journal Science. “We were pleased to see that the mice did not show signs of toxicity from CDD-2807 treatment, that the compound did not accumulate in the brain and that the treatment did not alter testis size,” said researcher Courtney Sutton, a postdoctoral fellow in pathology at Baylor College of Medicine in Houston. “Importantly, the contraceptive effect was reversible,” Sutton added in a Baylor news release. “After a period without compound CDD-2807, the mice recovered sperm motility and numbers and were fertile again.” Previous research had shown that naturally occurring mutations in STK33 leads to infertility in both mice and men by causing abnormal sperm with poor movement. These mutations cause no other health problems. “STK33 is therefore considered a viable target with minimal safety concerns for contraception in men,” said researcher Dr. Martin Matzuk, director of…  read on >  read on >

Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side effects, said a team led by Urvashi Patel, of the Evernorth Research Institute in St. Louis. The drugs’ price tag could be a big factor: Wegovy (semaglutide) costs about $1,300 per month, for example. “Each 1–percentage point increase in out-of-pocket cost per a 30-day supply of GLP-1 agonist was associated with increased odds of discontinuation,” Patel’s group noted. They published the findings May 23 in the journal JAMA Network Open. The St. Louis team looked at information from a major U.S. drug database on the use of GLP-1 meds by adults from early 2021 through to the end of 2023. Tirzepatide (Zepbound) was excluded from the list of GLP-1 meds because it was only approved by the U.S. Food and Drug Administration at the end of 2023. The database of nearly 196,000 patients found that by three months after starting a GLP-1 drug, just over 26% of users had already discontinued use; by six months that had risen to just under 31%, and by a year out 36.5% had stopped taking their GLP-1…  read on >  read on >

About 1 in 9 American children have ever received an ADHD diagnosis, slightly more than the number of kids currently being treated for the disorder, a new study shows. About 7.1 million kids (11.4%) have ever been diagnosed with ADHD, according to findings published May 23 in the Journal of Clinical Child & Adolescent Psychology. Incidence appears to be rising: Approximately 1 million more children ages 3 to 17 had received an ADHD diagnosis in 2022 than in 2016, researchers found. About 6.5 million children (10.5%) currently live with ADHD, or about 93% of those who’ve ever been diagnosed, researchers found. Among kids currently dealing with ADHD, about 58% have moderate or severe ADHD and 78% have at least one other disorder, results show.   Nearly 54% of current ADHD patients have been prescribed medication for the disorder, and 44% have received behavioral treatment in the past year, researchers found. However, nearly one in three kids (30%) haven’t received any ADHD-specific treatment, results show. ADHD is more common in the United States than in other countries, the researchers found. For the study, researchers analyzed more than 45,000 interviews conducted as part of the 2022 National Survey of Children’s Health. “Public awareness of ADHD has changed over time,” the researchers said. “With increased awareness of symptoms related to attention regulation, ADHD has been increasingly recognized in girls,…  read on >  read on >

A mom or dad who vapes at home might be setting their child up for eczema, new research suggests. In a study involving data from over 35,000 U.S. households, children with a parent who used e-cigarettes had a 24% higher odds for eczema (also known as atopic dermatitis) than kids with two non-vaping parents did. “Our results suggest that parental e-cigarette use was associated with pediatric atopic dermatitis,” concluded a team led by Dr. Golara Honari, a clinical associate professor of dermatology at Stanford University, in California. Her team published its findings May 22 in the journal JAMA Dermatology. According to the researchers, there is science backing up the notion that exposure to the toxins emitted in e-cigarette vapor could trigger changes in children’s skin. Prior lab studies have “demonstrated increased oxidative stress in human keratinocytes and 3-dimensional skin models exposed to e-cigarette fluids and aerosol residues,” they noted. Keratinocytes are cells that make up about 90% of the skin’s outer epidermal layer. “We hypothesize that secondhand exposure to e-cigarettes is associated with a similar response among children, elevating atopic dermatitis risk,” the Stanford team wrote. The new study drew on 2014-2018 data from the National Health Interview Survey, involving about 35,000 households. It’s a face-to-face survey of families conducted by the U.S. Centers for Disease Control and Prevention. Parents were asked about any cases…  read on >  read on >

Specific nutrients could play a pivotal role in the healthy aging of your brain, a new study finds. What’s more, those nutrients correlate closely with those found in the Mediterranean diet, an eating pattern already associated with healthy brain aging, researchers report. The identified nutrients “align with the extensive body of research in the field demonstrating the positive health effects of the Mediterranean Diet, which emphasizes foods rich in these beneficial nutrients,” said senior researcher Aron Barbey, director of the University of Nebraska–Lincoln’s Center for Brain, Biology and Behavior. For the study, researchers took blood samples and performed brain function tests and MRI scans on 100 cognitively healthy people ages 65 to 75. Analysis revealed two different types of brain aging among the participants, accelerated and slower than expected. Those with slower brain aging had a distinct nutrient profile in their blood samples, results show. The beneficial nutrient blood biomarkers included a combination of: Fatty acids (vaccenic, gondoic, alpha linolenic, elcosapentaenoic, eicosadienoic and lignoceric acids). Antioxidants and carotenoids including cis-lutein, trans-lutein and zeaxanthin Two forms of vitamin E. Choline, an essential nutrient. This profile correlates closely with that of the Mediterranean diet, researchers noted. These nutrient patterns “are promising and have favorable associations with measures of cognitive performance and brain health,” Barbey said in a university news release. Previous research on nutrition and brain aging…  read on >  read on >

The number of American teens and young adults who’ve been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds. That’s compared to an overall decline of about 3% in young Americans’ use of other types of prescription meds. But how safe are drugs like Ozempic, Wegovy, Mounjaro and Zepbound for young users? That remains unclear, said a team led by Dr. Joyce Lee, a professor of pediatrics at the University of Michigan Medical School in Ann Arbor. “Evaluation of the long-term safety, efficacy and cost- effectiveness of GLP-1RAs in adolescents and young adults is needed,” her team wrote. The findings were published May 22 in the Journal of the American Medical Association. The new study used a major U.S. prescription drug database to calculate the medication use of adolescents (ages 12 to 17) and young adults (ages 18 to 25) for the years 2020 through 2023. Besides the four drugs mentioned above, the GLP-1 meds that were tracked included dulaglutide (Trulicity), exenatide (Byetta) and liraglutide (Saxenda). Lee’s team found that over the three years of the study, GLP-1 prescriptions among people ages 12 to 25 jumped by more than 594% (equivalent to a nearly sevenfold rise). In sheer numbers, that means that while 8,722 Americans in this age group took a GLP-1 in 2020, 60,567…  read on >  read on >

Many people have been caught by surprise when an electric-powered car has smoothly and silently crept up on them as they walked. But such an accident can pose a very serious risk to life and limb, and pedestrians might be twice as likely to be hit by an electric or hybrid car than a gas-powered vehicle, researchers reported May 21 in the Journal of Epidemiology & Community Health. It’s even more risky in urban areas, with people there more than three times as likely to be hit by an electric car compared to a gas-powered model, researchers found. “Drivers of electric or hybrid-electric cars must be cautious of pedestrians who may not hear them approaching and may step into the road thinking it is safe to do so, particularly in towns and cities,” said the team led by Phil Edwards, an epidemiologist with the London School of Hygiene and Tropical Medicine. “The greater risk to pedestrian safety posed by electric or hybrid-electric cars needs to be mitigated as governments proceed to phase out petrol and diesel cars,” the researchers wrote. Traffic injuries are the leading cause of death for children and young people, researchers said, adding that pedestrians represent 1 in 4 traffic deaths. To study the potential added risk from electric vehicles, researchers analyzed UK data from 2013 to 2017 on pedestrian deaths and…  read on >  read on >